Metraipolis › archive › dc_ee191c30a850

First-Line Aumolertinib in EGFR -Mutant Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Retrospective Study with a Four-Year Follow-Up — Europe PMC PMID:40918464

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40918464
DOI
10.32604/or.2025.064119
License (as archived)
solo-consultazione
Archived
2026-11-10T07:08:26.223Z
SHA-256 of the archived text
d6cda8a1fd9c430daf09d951753850563fcb111e7890a4303c25262bca145e46
Stable URL of this page
https://metraipolis.com/documento/dc_ee191c30a850

How to cite

First-Line Aumolertinib in EGFR -Mutant Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Retrospective Study with a Four-Year Follow-Up — Europe PMC PMID:40918464 — Europe PMC (en), https://europepmc.org/article/MED/40918464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee191c30a850 (Metraipolis archive dc_ee191c30a850, sha256 d6cda8a1fd9c430daf09d951753850563fcb111e7890a4303c25262bca145e46)
BibTeX
@misc{dcee191c30a850,
  title = {First-Line Aumolertinib in EGFR -Mutant Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Retrospective Study with a Four-Year Follow-Up — Europe PMC PMID:40918464},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40918464},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee191c30a850; sha256 d6cda8a1fd9c430daf09d951753850563fcb111e7890a4303c25262bca145e46},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40918464. Agents can read the archived copy with the MCP tool read_document.